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EDITORIAL
More questions than answers
The child whose idiopathic nephrotic syndrome (INS) nature of the disease process [3]. This claim that the
defies treatment presents the greatest of challenges to segmental sclerotic lesion is nonspecific is reinforced by
the skills of the pediatric nephrologist. The majority of the fact that a similar lesion can be seen in other condi-
such patients, on renal biopsy, are found to have the tions with persistent proteinuria such as HIV nephropa-
lesion of focal segmental glomerulosclerosis (FSGS), thy, the focal sclerosis of sickle cell disease, and diabetic
where segments of one or more glomeruli are sclerotic. nephropathy. If MCNS and FSGS are different ends of
The glomeruli in the juxtamedullary region are the most the spectrum of the same disease, we are left with the
likely to be affected by this lesion. With time, more and question, why is the disease progressing in a larger per-
more glomeruli are affected, glomeruli become totally centage of children? Is it, as Bonilla-Felix et al suggest,
sclerotic, and renal failure may develop and progress to secondary to an environmental factor? Is this environ-
end-stage renal disease. Some of the patients will have mental factor infectious, related to a virus, or is it related
recurrence of the nephrotic syndrome after transplanta- to chemical exposures or, more likely, are many factors
tion and eventually show this typical sclerotic lesion on involved?
biopsy of the transplanted kidney, though early in the Genetic factors appear to play a role, as there is a
evolution of the recurrence, the biopsy is more typical higher and increasing incidence of the FSGS lesion in
of minimal change nephrotic syndrome (MCNS). African American children, shown not only in the Bo-
It has seemed to many of us over the past few years that nilla-Felix study [1] but in several other studies [4, 5].
we are seeing more children who have difficult nephrotic Bonilla-Felix also show a lower incidence in Hispanic
syndrome and FSGS, and the paper by Bonilla-Felix et children.
al in this issue of Kidney International confirms that feel- In spite of the predilection of children with the FSGS
ing [1]. We have no idea why this is happening. In consid- lesion to respond poorly to therapy, those who do re-
ering the issue, the first questions to ask are: what is this spond tend to have a prognosis more similar to that of
condition called focal segmental glomerulosclerosis? Is the child with MCNS. The achievement of long-term
it a unique disease, is it a variant of MCNS, or is there remission is a stronger correlate of a favorable prognosis
a continuum of several related diseases, with MCNS the than is the presence or absence of a specific finding such
most benign of the group? If MCNS and FSGS are the as segmental sclerosis or mesangial hypercellularity on
same disease and signify different ends of the severity biopsy [3, 6].
spectrum of a single or related group of diseases, why It is clear that we have a very poor understanding of
the increase in severity? The more one reads and asks, the disease process in children with INS. We know that
the more apparent our lack of understanding becomes; the condition is associated with multiple abnormalities
we know very little about INS in childhood. of the immune system, some likely etiologic and others
The lesion of FSGS is eventually, but not necessarily secondary to the disease process [7], and we know that
initially, present on biopsy in the majority of children immunosuppressive therapies are effective in many pa-
with INS who are resistant to steroid therapy, and also tients [2, 8], but we frequently fail to predict which ther-
is present in many of those who respond to steroids with apy will help which patient, or if a given patient will
remission of the nephrotic syndrome but become steroid- respond to any therapy. As a result, we expose some
dependent to sustain that remission [2]. Does prolonged patients to very toxic therapies such as high dose steroids,
proteinuria in such children cause glomerular injury, re- alkalating agents and cyclosporine, with no benefit. We
sulting in the FSGS lesion, or is the lesion a specific don’t know the basic cause or causes of INS, and we
indicator of a unique and more severe disease? McA- don’t understand the role or meaning, if any, of the
dams, Valentini and Welch et al argue that the lesion of specific FSGS lesion in the steroid-dependent or resistant
segmental glomerulosclerosis is not a specific marker for patient. Cameron very nicely sums up the situation in
a subtype of INS, but reflects instead the progressive his statement: “The most important fact to remember
about focal glomerulosclerosis (FSGS) is that it is a glo-
merular appearance seen on histological examination ofKey words: idiopathic nephrotic syndrome, childhood renal disease,
lesions, focal segmental glomerulosclerosis. the kidney and not a disease entity” [9]. In order to
advance our knowledge and better correlate the patho- 1999 by the International Society of Nephrology
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